Pasithea Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.48

+0.00 (+0.52%)

As of Aug 14, 10:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,502.5% upside

Low Target $19.73

Average Target $26.92

High Target $29.00

Current Price $0.48

Current
$0.48

Target
$26.92

$19.73 $26.92 avg $29.00

Scenario Analysis

Bear Case

$19.73

4,006.1%

Low target

Base Case

$26.92

+5,502.5%

Avg target

Bull Case

$29.00

+5,935.4%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$2.06

-76.7% from high

52-Week Low

$0.28

+71.0% from low

Target vs 52W High

$26.92

+1,206.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%